171 results
Page 3 of 9
424B5
tbfmlipj55gtnakplyra
7 Jul 20
Prospectus supplement for primary offering
4:32pm
10-K
rqzeaa6o 332jotlfz
29 Jun 20
Annual report
4:02pm
8-K
EX-99.1
fwabyajf2uowhf5wpl7
29 Jun 20
Acasti Pharma Provides Fiscal 2020 Year-End Business Update
12:50pm
S-3
eaoae
29 Jun 20
Shelf registration
12:00am
8-K
EX-99.1
6ucv28c8
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
EX-99.1
4ryaqq6wr3jg
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
EX-99.1
xggeoyez81u5ahh2
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
EX-99.1
xc32o7z6r aq4ow
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
EX-99.1
zbmxesrp7jhz98 lb1
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
EX-99.1
5ratijxv
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
EX-99.2
n07fm
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
ir2law
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
vwbqnyp 65fsz
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
pfna8r7nhz8lpl4vh2
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
EX-99.1
1wfzf dzc
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
EX-99.1
5zj9twpg q40je
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
EX-99.1
52bzmmtdej4zshdebz
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
EX-99.1
vx9wlmb ud
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
EX-99.1
vwr l3yh7v
18 Nov 19
Current report (foreign)
8:46am
6-K
EX-99.1
evu utp9bgm
13 Nov 19
Current report (foreign)
7:55am